Conduta fisioterapêutica na esclerose lateral amiotrófica

Autores

  • Andreza Martinez Pozza Faculdade de Medicina de São José do Rio Preto
  • Milene Karenine Delamura Faculdade de Medicina de São José do Rio Preto
  • Clarissa Ramirez Faculdade de Medicina de São José do Rio Preto
  • Nelson Iguimar Valério Faculdade de Medicina de São José do Rio Preto
  • Laís Helena Carvalho Marino Faculdade de Medicina de São José do Rio Preto
  • Neuseli Marino Lamari Faculdade de Medicina de São José do Rio Preto

Palavras-chave:

Esclerose amiotrófica lateral, Reabilitação, Exercícios respiratórios, Doenças neurodegenerativas, Qualidade de vida

Resumo

Esclerose lateral amiotrófica (ELA) é uma doença neurodegenerativa progressiva, fatal, de etiologia multifatorial e sem tratamento medicamentoso efetivo até o momento. Entretanto, a fisioterapia, por meio de intervenções cinesioterapêuticas e orientações aos pacientes e aos cuidadores, ameniza a perda físico-funcional, a fadiga muscular e a imobilidade do sistema músculo-esquelético, melhorando a qualidade de vida. Buscou-se neste trabalho sugerir os procedimentos fisioterapêuticos utilizados atualmente na ELA. Indica-se realizar acompanhamentos mensais com mudanças nos objetivos e nas condutas a cada fase da doença e propõe-se acompanhamento das atividades em domicílio, com ênfase em alongamentos, fortalecimento muscular, adequação postural e cinesioterapia respiratória.

Downloads

Não há dados estatísticos.

Biografia do Autor

Andreza Martinez Pozza, Faculdade de Medicina de São José do Rio Preto

Physiotherapist and student on the Lato Sensu postgraduate course in Hospital Physiotherapy at Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, São Paulo, Brazil.

Milene Karenine Delamura, Faculdade de Medicina de São José do Rio Preto

Physiotherapist and student on the Lato Sensu postgraduate course on hospital physiotherapy at Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, São Paulo, Brazil.

Clarissa Ramirez, Faculdade de Medicina de São José do Rio Preto

MSc. Physiotherapist, specialist in neurological physiotherapy. Professor of Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, São Paulo, Brazil.

Nelson Iguimar Valério, Faculdade de Medicina de São José do Rio Preto

PhD. Psychologist, associate professor of Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, São Paulo, Brazil.

Laís Helena Carvalho Marino, Faculdade de Medicina de São José do Rio Preto

Physiotherapist, specialist in hospital physiotherapy at Faculdade Medicina de São José do Rio Preto, and Supervisor of Physiotherapeutic Improvement at Hospital de Base de São José do Rio Preto, São José do Rio Preto, São Paulo, Brazil.

Neuseli Marino Lamari, Faculdade de Medicina de São José do Rio Preto

PhD. Physiotherapist, associate professor of Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, São Paulo, Brazil.

Referências

Wicklund MP. Amyotrophic lateral sclerosis: possible role of environmental influences. Neurol Clin. 2005;23(2): 461-84.

Belsh JM. Diagnostic challenges in ALS. Neurology. 1999;53(8 Suppl 5):S26-30; discussion S35-6.

Majoor-Krakauer D, Willems PJ, Hofman A. Genetic epidemiology of amyotrophic lateral sclerosis. Clin Genet. 2003;63(2):83-101.

Kirby J, Halligan E, Baptista MJ, et al. Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS. Brain. 2005;128(Pt 7):1686-706.

Shipe C, Zivkovic SA. Electrodiagnostic evaluation of mo- tor neuron disorders. Am J Electroneurodiagnostic Technol. 2004;44(1):30-6.

González-Lorenzo F, Díaz-Lobato S. Soporte ventilatorio en pacientes con esclerosis lateral amiotrófica. [Mechanical ventila- tion in patients with amyotrophic lateral sclerosis]. Rev Neurol. 2000;30(1):61-4.

Dal Bello-Haas V, Kloos AD, Mitsumoto H. Physical therapy for a patient through six stages of amyotrophic lateral sclerosis. Phys Ther. 1998;78(12):1312-24.

Dietrich-Neto F, Callegaro D, Dias-Tosta E, et al. Amyotrophic lateral sclerosis in Brazil: 1998 national survey. Arq Neurop- siquiatr. 2000;58(3A):607-15.

Pouget J, Azulay JP, Bille-Turc F, Sangla I, Serratrice GT. The diagnosis of amyotrophic lateral sclerosis. Adv Neurol. 1995;68:143-52.

Le Forestier N. Diagnostics différentiels de la sclerose latérale amyotrophique. [The differential diagnosis of amyotrophic lateral sclerosis]. Rev Med Liege. 2004;59(Suppl 1):25-31.

McGeer EG, McGeer PL. Pharmacologic approaches to the treatment of amyotrophic lateral sclerosis. BioDrugs. 2005;19(1):31-7.

Ellis AC, Rosenfeld J. The role of creatine in the management of amyotrophic lateral sclerosis and other neurodegenerative disorders. CNS Drugs. 2004;18(14):967-80.

Ascherio A, Weisskopf MG, O’Reilly EJ, et al. Vitamin E intake and risk of amyotrophic lateral sclerosis. Ann Neurol. 2005;57(1):104-10.

Gómez Fernández L, Calzada Sierra DJ. Importancia del tratamiento rehabilitador multifactorial en la esclerosis lateral amiotrófica. [The importance of multifactorial rehabilitation treatment in amyotrophic lateral sclerosis]. Rev Neurol. 2001;32(5):423-6.

Piemonte MEP, Ramirez C. Como este manual pode ajudar. Piemonte MEP, editor. Manual de exercícios domiciliares para pacientes com esclerose lateral amiotrófica. São Paulo: Manole; 2001. p. 19-64.

Pedroso JPC, Ramirez C, Silva HCA, et al. Importance of the physical therapeutic program in muscular force and the functional state in patients with amyotrophic lateral sclerosis during 6 months. Proceedings of the 12th International Symposium on ALS/MND; 2001 Nov 18-20; Oakland, USA; 2001. p. 94.

Duran MA, Reis RG, Oliveira ASB, et al. Orientations of the motor physiotherapy to the caregivers, relatives and patients with ALS. Arq Neuropsiquiatr. 2002;60(Supl 1). [abstract].

Drory VE, Goltsman E, Reznik JG, Mosek A, Korczyn AD. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2001;191(1-2):133-7.

Haerer AF. DeJong’s neurologic examination. 5th ed. Philadel- phia: JB Lippincott Company; 1992.

Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67(2):206-7.

The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assess- ment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. Arch Neurol. 1996;53(2):141-7.

Schwartz JE, Jandorf L, Krupp LB. The measurement of fatigue: a new instrument. J Psychosom Res. 1993;37(7):753-62.

Cohen SR, Mount BM, Strobel MG, Bui F. The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med. 1995;9(3):207-19.

Wallerstein SL. Scaling clinical pain and pain relief. In: Bromm B, editor. Pain measurement in man: neurophysiological cor- relates of pain. New York: Elsevier; 1984.

Ramirez C. Fadiga na esclerose lateral amiotrófica: freqüência e fatores associados. [Fatigue in amyotrophic lateral sclerosis: associated factors and frequency]. [dissertation]. São Paulo: Faculdade de Medicina da Universidade de São Paulo; 2004.

Van den Berg-Vos RM, Visser J, Franssen H, de Visser M, Wokke JHJ, Van den Berg LH. Sporadic lower motor neuron disease with adult onset: classification of subtypes. Proceedings of the 12th International Symposium on ALS/MND; 2001 Nov 18-20; Oakland, USA; 2001. p. 42.

Scarmeas N, Shih T, Stern Y, Ottman R, Rowland LP. Premorbid weight, body mass, and varsity athletics in ALS. Neurology. 2002;59(5):773-5.

Chio A, Benzi G, Dossena M, Mutani R, Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain. 2005;128(Pt 3):472-6.

Miller RG, Rosenberg JA, Gelinas DF, et al. Practice param- eter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52(7): 1311-23.

Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman-Pat- terson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci. 1999;164(1):82-8.

Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommit- tee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci. 1994;124(Suppl):96-107.

Pinto AC, Evangelista T, de Carvalho M, Paiva T, de Lurdes Sales-Luís M. Respiratory disorders in ALS: sleep and exercise studies. J Neurol Sci. 1999;169(1-2):61-8.

Bourke SC, Bullock RE, Williams TL, Shaw PJ, Gibson GJ. Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology. 2003;61(2):171-7.

Barthlen GM, Lange DJ. Unexpectedly severe sleep and respira- tory pathology in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2000;7(3):299-302.

Downloads

Publicado

2006-11-11

Como Citar

1.
Pozza AM, Delamura MK, Ramirez C, Valério NI, Marino LHC, Lamari NM. Conduta fisioterapêutica na esclerose lateral amiotrófica. Sao Paulo Med J [Internet]. 11º de novembro de 2006 [citado 14º de março de 2025];124(6):350-4. Disponível em: https://periodicosapm.emnuvens.com.br/spmj/article/view/2297

Edição

v. 124 n. 6 (2006)

Seção

Artigo de Revisão

Licença

Creative Commons License
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.